Pulmonary Embolism Right Ventricular Dysfunction (RVD) Index Calculator

Clinical calculation support · Verify results before clinical use

Clinical inputs

Enter available CT, echocardiographic, biomarker, and clot-burden findings. Use the local assay reference limit.

—Index

The composite is research-informed but not externally validated. Its weights and bands must not be used as a stand-alone clinical risk model.

Component interpretation

These flags summarize selected structural, functional, biomarker, and clot-burden findings in acute pulmonary embolism (PE). They are not interchangeable and do not independently define overall PE risk.

ComponentRule in this toolClinical context
CT RV/LV ratio≥ 1.0CT evidence of RV enlargement associated with adverse prognosis in acute PE.
TAPSE< 16 mmEcho marker associated with RV systolic dysfunction/adverse prognosis; interpret with the full study.
TroponinAbove assay-specific ULNMyocardial injury marker; alone it has limited specificity for early mortality in normotensive PE.
NT-proBNP≥ 600 pg/mLESC guideline discusses ≥600 ng/L as additional prognostic information; ng/L and pg/mL are numerically equivalent.
PAOI≥ 40%Qanadli/Mastora quantify clot burden; the exact 40% threshold and its weight in this composite are not established here as a validated decision rule.

Important limitations

  • The 2/2/1/1/1 weights and score bands are retained from the source code; no derivation or external validation for this exact composite was identified in the sources reviewed.
  • Original “low/intermediate/high” labels could be mistaken for guideline-defined PE risk classes. They are shown here as exploratory component-count bands only.
  • Entering 0 for unavailable NT-proBNP or PAOI makes the algorithm count that component as below threshold and can undercount findings.
  • Do not delay urgent evaluation or treatment of hemodynamic instability to complete this calculator.

References

Konstantinides SV, Meyer G, Becattini C, et al.2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the ERS. Eur Heart J. 2020;41:543–603. DOI: 10.1093/eurheartj/ehz405.
European Society of Cardiology.2019 Guidelines on Acute Pulmonary Embolism: official guideline page. ESC guideline resource.

These sources support component-level context and guideline risk-stratification principles; they do not validate this exact composite or its weights.

Clinical disclaimer: This educational calculator is not a validated prognostic model and must not replace guideline-based PE risk stratification, clinician assessment, or local protocols. Risk assessment should begin with hemodynamic stability and incorporate clinical severity, comorbidities, validated scores, imaging, and biomarkers as appropriate.